Tue, Sep 2, 2014, 7:45 AM EDT - U.S. Markets open in 1 hr 45 mins


% | $
Quotes you view appear here for quick access.

YM BioSciences, Inc. Ordinary S Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • mdv_92126 mdv_92126 Dec 8, 2005 7:31 PM Flag

    Promise-keeping enterprise?

    John, It is still Q4.

    BTW, look at SLIDE 14:
    YMI put in a slide about Merck and Takeda's partnership re Matuzumab and financials. Why?
    Has nothing to do with the overall YMI corp presentation.
    My take: they are sending the subliminal message that there will be a substantial partnership(s) for Nimotuzumab. And why not...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • >John, It is still Q4<

      I know, I know. If they do deliver on their promises, I will be pleased.

      I have to admit I am frustrated because this company is so great--why the hell are we still at ~$3.00? I see total POS companies with a single product in stage 2 that are worth 3 to 5 times YMI.

      Regarding slide 14: Have you had a chance to listen to the R&R Conference? Allan's commentary on the Merck/Takeda slide was not-too-subliminal. Let's hope there is something similar in the cards for YMI. Soon would be nice.

      Just needed to vent, anyway. Part of my problem is that I was growing used to big returns in a few months--it's been a very good two years for my biotech portfolio. Now I just need to relearn patience.

      • 1 Reply to rfj1862
      • I share your frustration...most of my shares are now long-term cap gains.

        I take comfort in knowing that ANY of their products, if successful, will markedly increase the paltry market cap. Taken together, they will add up substantially.

        I also like the odds of chasing a 140% OS sub-group to achieve a 50% benefit in a pivotal trial. And they still maintain their belief in "mid-2006." I think it foolish to believe the company is totally-blinded, even if they only have anecdotal evidentiary data.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.